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Abstract
Accumulated evidence demonstrates the existence of bone marrow-derived cells origin in the endometria of women
undergoing bone marrow transplantation (BMT). In these reports, cells of a bone marrow (BM) origin are able to
differentiate into endometrial cells, although their contribution to endometrial regeneration is not yet clear. We have
previously demonstrated the functional relevance of side population (SP) cells as the endogenous source of somatic stem
cells (SSC) in the human endometrium. The present work aims to understand the presence and contribution of bone
marrow-derived cells to the endometrium and the endometrial SP population of women who received BMT from male
donors. Five female recipients with spontaneous or induced menstruations were selected and their endometrium was
examined for the contribution of XY donor-derived cells using fluorescent in situ hybridization (FISH), telomapping and SP
method investigation. We confirm the presence of XY donor-derived cells in the recipient endometrium ranging from 1.7%
to 2.62%. We also identify 0.45–0.85% of the donor-derived cells in the epithelial compartment displaying CD9 marker, and
1.0–1.83% of the Vimentin-positive XY donor-derived cells in the stromal compartment. Although the percentage of
endometrial SP cells decreased, possibly being due to chemotherapy applied to these patients, they were not formed by XY
donor-derived cells, donor BM cells were not associated with the stem cell (SC) niches assessed by telomapping technique,
and engraftment percentages were very low with no correlation between time from transplant and engraftment efficiency,
suggesting random terminal differentiation. In conclusion, XY donor-derived cells of a BM origin may be considered a
limited exogenous source of transdifferentiated endometrial cells rather than a cyclic source of BM donor-derived stem cells.
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Introduction
In the absence of pregnancy, the endometrial lining is removed
every month and a new one is rebuilt under the control of steroid
hormonal signals. This regenerative process occurs incessantly
some 400 times throughout women’s reproductive lifespan [1].
It has been associated with the existence of a relevant resident
somatic stem cell (SSC) population in this tissue. Different groups
have suggested the existence of this endometrial SSC in mice [2–3]
and in humans [4–17], and to be hypothetically located near
vessels in the basalis [18–21].
The side population (SP) phenotype, defined as cells capacity to
extrude the DNA binding dye (Hoechst 33342) via the ATP-
binding cassette transporter, was originally described as a marker
of bone marrow stem cells (SC) [22]. It has been used to identify
SC from many organs and tissues, such as the mammary gland
[23], skin [24], myometrium [25], lung [26] and dental pulp [27].
In the human endometrium, several independent groups have
demonstrated that SP cells functionally contribute to in vitro and in
vivo tissue regeneration [18,20,28–29].
Bone marrow (BM) cells are able to differentiate into multiple
nonhematopoietic cells [30–31]. In fact in human recipients who
have received bone marrow transplantation (BMT), donor-
derived cells have been proven to differentiate into hepa-
tocytes [32], neurons [33], cardiomyocytes [34] and skin [35–
36].
Donor-derived cells that are histologically and immunohisto-
chemically similar to epithelial and stromal cells have been
detected in the endometria of BM recipients [37–40]. This finding
suggests a potential exogenous source for endometrial regenera-
tion that can take place after BM mobilization as a normal
physiologic process or under pathological conditions; e.g.,
chemotherapy preceding BMT.
The aim of this study was to address the question of whether
BM donor-derived cells contribute to the endometrial SP
population of recipients and, therefore, if they contribute to the
endogenous source of SSC or not. To this end, a clinical model of
female BMT recipients who received BM from human leukocyte
antigen (HLA)-identical male donors was used.
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Ethics Statement
Five female patients who received an allogeneic SC transplan-
tation from male donors for the treatment of hematological
malignancies at the Hematology Department, Hospital Universi-
tario La Fe, Valencia, Spain from May to October in 2010, were
enrolled in this study.
This project was approved by the institutional review board of
Hospital Universitario La Fe registered under number 2009/0364,
and all patients gave written informed consent.
Patients and tissue samples
Recipients’ ages ranged between 28 and 41 years. Transplant
was performed to treat a variety of hematological malignancies:
chronic myeloid leukemia (CML) in two patients; acute myelo-
blastic leukemia (AMbL) in two patients; and acute lymphoblastic
leukemia (ALL) in one patient. All the patients received a busulfan-
based myeloablative conditioning regimen without total body
irradiation (TBI). Patients 1, 2 and 5 received transplantation from
unrelated donor umbilical cord blood (UD-UCB). Patient 3
received an HLA-matched unrelated bone marrow transplant
(UD-BMT). Finally, patient 4 was transplanted using mobilized
peripheral blood stem cells (PBSC) from an HLA-matched sibling
donor (see Table 1).
Patients with secondary amenorrhea after transplantation
received hormone replacement therapy (HRT) using a Gonado-
tropin-releasing hormone agonist depot (GnRH-a) (Decapeptyl
3.75, IPSEN, France) injected on day 21 of the previous cycle.
Estradiol valerate (EV) (Progynova; Schering Spain, Madrid,
Spain), 6 mgr daily, was initiated on day 2 of the cycle for at least
10 days, while progesterone (Utrogestan, Corne, Mexico), 800 mg
per day, was added as previously described [41–42]. An
endometrial tissue specimen was obtained with a Pipelle catheter
(Gynetics Medical Products N.V, #4164 probet, Belgium) under
sterile conditions from the uterine fundus at a minimum of 4
months from starting HRT. Histological sections from three
patients without transplantation were used as positive controls to
detect the absence of chromosome Y signals.
Study design
The endometrial samples obtained from all five BMT recipients
were divided and processed as formalin-fixed paraffin embedded
and enzymatically disaggregated viable single cell suspensions.
Paraffin embedded tissues were examined using fluorescent in situ
hybridization (FISH) to target chromosomes X and Y, immuno-
histochemistry was done to immunophenotype endometrial XY
cells, while a telomapping analysis was carried out for telomere
quantification purposes. The cell suspensions from the same
specimens were processed to isolate SP cells as previously
described [20,29] to be then FISH analyzed.
Fluorescence In Situ Hybridization (FISH)
A fluorescence in situ hybridization analysis was performed with
the specific probes for chromosomes X and Y (CEP Probes,
Abbot). Paraffin embedded slides were deparaffinized at 60u
overnight. Afterward, sections were cleared with xylene for
10 minutes, and twice re-hydrated in several washes with 100%,
85% and 70% ethanol for 5 minutes each. Then slides were rinsed
with distilled water (dH2O) for 5 min at room temperature (RT).
Antigen retrieval was done with citrate buffer 10 mM (pH 8.0) in a
microwave within a humidified chamber for 5-min periods at a
high temperature. For enzymatic digestion, hydrochloric acid
0.2 M was used for 10 minutes, and slides were continuously
treated with Proteinase K 10 mg/mL for 10 minutes in a bath at
37uC. Slides were rinsed with saline-sodium citrate buffer (26
SSC) 5 min and fixed with 1% paraformaldehyde buffer for
10 minutes before being rinsed again with 26SSC buffer 5 min
and air dried.
Next, slides were dehydrated in a battery with ethanol prior to
hybridization with the probes. The mixture of probes was added to
the slides, covered with coverslips and incubated in a humidified
chamber at 80uC for 5 minutes for denaturation and at 37uC for
72 hours for hybridization. Afterward, slides were washed with
0.46SSC buffer / 0.3% NP40 (nonyl phenoxypolyethoxylethanol)
pH 7.5 in a bath at 80uC for 2 minutes and then with 26SSC/
0.1% NP40 pH 7.2 at RT. Finally, nuclei were stained with
diamidino-2-phenylindole dihydrochloride (DAPI).
Tissue controls for the X and Y signals were the endometria
from patients without transplantation and fetal testes, respectively.
Quantification of XY donor-derived cells
Slides were observed under a fluorescence microscope (Leica
DM 6000 B/M) at a 636 magnification with oil immersion
objective. Female cells, represented by two X chromosomes,
shared the same color (spectrum orange) FISH signals, corre-
sponding to the X chromosomes, whereas male cells, XY
chromosomes, displayed two different colors (spectrums orange
and green) FISH signals, representing both chromosomes. A range
of 1000–1500 nonoverlapping cells was counted to analyze the
percentage of XY cells within the recipient endometrium. Total
numbers of XX and XY cells were quantified with the Image-Pro
Plus Software Version 6.3 (MediaCybernetics).












1 38 4 Yes 132 CML CBSC (0)
2 29 15 No 30 AMbL CBSC(0)
3 41 72 Yes 210 CML BM (46)
4 34 36 No 116 ALL PBSC (21)
5* 28 18 No 45 AMbL CBSC(0)
CBSC, Cord Blood Stem Cell; BM, Bone Marrow; PBSC, Peripheral Blood Stem Cells; HRT, Hormone Replacement Therapy. (*atrophic endometrium).
doi:10.1371/journal.pone.0030260.t001
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hybridization
The telomapping technique [43–44] was followed to localize the
putative niches of SSC represented by the hot regions associated
with large telomeres.
The above-described telomapping method was based on the
telomere length quantification on interphase nuclei. Therefore,
slides were hybridized with a PNA-tel Cy3-labeled probe. Briefly,
DAPI and Cy3 signals were acquired simultaneously in separate
channels using a confocal ultra spectral microscope (Leica TCS-
SP2-A-OBS-UV). The binary DAPI mask was applied to the
matching Cy3 to obtain a combined image with each nucleus
telomere fluorescence information. Cy3 fluorescence intensity
(telomere fluorescence) was measured as the ‘‘average gray value’’
(total gray value/nuclei area) units (arbitrary units of fluorescence).
These ‘‘average telomere fluorescence’’ values always represent
the average Cy3 pixel intensity for the total nuclear area, and not
the average value of individual telomere spot intensities, therefore
ruling out that differences in nuclear size may influence telomere
length measurements.
Immunofluorescence and confocal analysis for CD45,
CD9 and Vimentin
To immunophenotype the XY donor-derived cells, CD45, CD9
and Vimentin were analyzed. After hybridization with sex
chromosomes, slides were washed with phosphate buffered saline
(PBS). Prior to antibody incubation, slides were blocked with PBS
supplemented with 3% Bovine Serum Albumin (BSA), 5% Normal
Goat Serum (NGS) and 0.05% Tween-20 for one hour at RT to
treat nonspecific unions. Following this, overnight incubation with
a primary antibody was applied; the specific antibodies used in this
study were mouse anti-human CD45 (BD Pharmingen, 555480),
mouse anti-human CD9 (Abcam, 49325) and mouse anti-human
Vimentin (Vm) (Abcam, 8069). Next, slides were washed with PBS
and incubated with the appropriate fluorescent secondary
antibody: Alexa 633 F(ab9)2 fragment goat anti-mouse (Invitrogen,
A-21053). Finally, slides were rinsed with PBS and dH2O.
Furthermore, nuclei were stained with DAPI.
The controls used were spleen for the CD45 expression
endometrium containing epithelial glands and stroma for CD9
and Vm, respectively.
Double labeling by FISH and immunofluorescence against
CD45-CD9-Vm were observed by confocal microscopy. Images
were acquired with a Leica TCS SP2 AOBS (Leica Microsystems
Heidelberg GmbH, Mannheim, Germany) inverted laser scanning
confocal microscope using a 636Plan-Apochromat-Lambda Blue
1.4 N.A. oil immersion objective. The excitation wavelengths for
fluorochromes were 488 nm for FITC (green), 561 nm for TRITC
(orange/red), 633 nm for Alexa633 (far red) and 405 nm for DAPI
(blue). Two-dimensional pseudo color images (255 color levels)
were acquired with a size of 102461024 pixels. All the confocal
images with the same settings and fluorescence distribution were
analyzed using the Leica ‘‘Leica Lite’’ Confocal Software, version
2.61.
The combination of different fluorophores allowed the charac-
terization of the XY cells with their corresponding phenotype.
Isolation of endometrial side population cells
Epithelial and stromal cell suspensions from an endometrial
biopsy were obtained by following a well-established protocol with
minor modifications [44]. Samples were washed to discard
remnants of blood and mucus to be then minced into small
fragments which were enzymatically digested with collagenase
type IA (Sigma-Aldrich, Spain) at 10 mg/ml in Dulbecco’s
Modified Eagle Medium (DMEM) (Sigma-Aldrich, Spain).
Gravity sedimentation and membrane filtration allowed the
separation of stromal cells and epithelial glands on a size basis
[45]. Cell suspensions were treated with erythrocyte lysis solution
and cell viability was also assessed with Propidium Iodide (PI;
5 mg/ml (Sigma-Aldrich, Spain)) to exclude any dead cells to be
analyzed.
Single cell suspensions were incubated in a bath at 37uC for
90 minutes with Hoechst 33342 dye 10 mg/mL (Sigma- Aldrich,
Spain) to identify and isolate side population (SP) cells as putative
endometrial SSC and non side population cells (NSP) [20].
After incubation, cells were centrifuged and resuspended in
Hank’s Buffered Salt Solution buffer (HBSS) (Gibco, Invitrogen,
Spain) supplemented with 2% Fetal Bovine Serum (FBS) (Gibco,
Invitrogen, Spain) and HEPES 10 mM pH 7.2 (Sigma- Aldrich,
Spain). Those cells labeled with Hoechst were analyzed and sorted
by a MoFloH (Dako, Denmark, http://www.dako.com) jet-in-air
high speed sorter. Excitation was performed with a water-cooled
Enterprise II ion laser (Coherent, CA, USA), which operated at
the 351 nm and 488 nm wavelengths, and worked at 30 mW.
Hoechst 33342 blue and red fluorescences were detected through
405/30 and 670/20 nm band-pass filters, respectively, by
measuring signals on a linear scale. PI fluorescence was detected
through a band-pass filter of 613/20 on a logarithmic scale. The
gates for cell sorting were defined to collect live cells with low
Hoechst 33342 fluorescence (SP fraction), as well as live cells with
high Hoechst 33342 fluorescence (NSP fraction).
FISH in cell suspensions
SP and NSP cells were cultured under hypoxic conditions (1–
2% O2) for 3 weeks. Cells were trypsinized, treated with chloride
potassium 0.075 M and fixed with 3 methanol:1 acetic acid to
proceed with the FISH analyses.
Slides with fixed cells were dehydrated in a battery with ethanol
(70%, 85% and 100%) for one minute each, and were air-dried. A
mixture of centromeric probes for chromosomes X (spectrum
orange), Y (spectrum green) and 18 (spectrum aqua) (Poseidon
probes, Kreatech, Spain) was added to the slides, which were
covered with coverslips and incubated in a humidified chamber at
73uC for 5 minutes for denaturation and at 37uC for overnight
hybridization. Afterward, slides were washed firstly with
0.46SSC/0.3% NP40 pH 7.5 in a bath at 73uC for 2 minutes
and secondly with 26SSC/0.1% NP40 pH 7.2 at RT. Finally,
nuclei were stained with DAPI.
Results
XY cells of donor origin in the endometria of BMT
recipients
The BMT recipients’ epidemiological characteristics in terms of
age, HRT duration, if they have been pregnant or not after BMT,
the time from BMT to the endometrial biopsy, indications for
transplant, and type of hematopoietic precursors used, are all
shown in Table 1.
We examined the presence of donor-derived cells (chromosome
Y-positive cells) in BM transplant recipients’ endometria using
FISH analyses. Tissue sections were analyzed by two observers
with a total of 5 visual fields per sample scored (around 1000–1500
cells). The results reveal the existence of XY donor-derived cells in
all the endometrial sections from the recipients analyzed (Figure 1A
and 1B). The donor-derived cells corresponding to chromosome
Y-positive cells accounted for 1.7–2.62% of the total cell count,
with less contribution to the epithelial compartment (ranging from
Bone Marrow Source of SC in Human Endometrium
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e30260Figure 1. Detection and quantification of XY cells from donor origin in the endometria of BMT recipients. (A&B) Human endometrial
sections from 2 different patients, who underwent BMT, showing a positive FISH signal corresponding to chromosome Y (green signal) and
chromosome X (orange signal) along both the epithelial and stromal compartments. Presence of donor-derived cells (chromosome Y-positive cells) in
the endometrium is indicated by arrows. Lower panels containing control slides: (A) endometrium as a positive control for the chromosome X signal
and (B) fetal testes as a positive control for the chromosome XY signal. (C) Table summarizing the characteristics of the recipients, the percentages of
XY-positive cells obtained in the whole endometrium, plus the epithelial and stromal fractions. All the images were acquired using a 636/1.66oil
immersion objective.
doi:10.1371/journal.pone.0030260.g001
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cells in the stromal compartment oscillated from 1.0% to 1.83%. It
is interesting to note that no correlation was found between the
time from transplantation to biopsy (from 30 to 210 months) and
the percentage of the chromosome Y-positive cells found in the
endometrium (Figure 1C).
Control FISH analyses included the endometria of healthy
patients without transplantation who had a previous pregnancy
carrying a boy to avoid the possibility of contamination of
chromosome Y-positive cells via materno-fetal chimerism and
male tissues from fetal testes. As expected, all the cells in our
controls exhibited orange (chromosome X-positive cells) signals
(Figure 1A, lower panel), whereas the ratio of the chromosome Y-
to chromosome X- positive cells was confirmed in male testes
(Figure 1B, lower panel). Moreover, the possibility of cell fusion
was ruled out given the absence of aneuploidies.
Immunophenotyping of the XY donor-derived cells in the
endometria of transplanted patients
In order to clarify the final differentiation of the XY donor-
derived cells in the endometrium, we used a battery of markers
composed of CD45 for cells of a hematopoietic origin, CD9 and
Vm for endometrial epithelial and stromal cells, respectively.
These markers were co-localized in combination with chromo-
some Y detection.
As a result, we observed that none of the XY donor-derived cells
were CD45-positive, which rules out the possibility of hematopoi-
etic progenitors and contamination by resident leukocytes
originating from BMT (Figure 2A). All the XY donor-derived
cells present in the glands were CD9-positive (Figure 2B), and all
the XY donor-derived cells in the stroma colocalized with Vm
marker (Figure 2C), suggesting a final tissue-specific differentiation
of XY donor-derived cells. Finally, spleen and endometrium were
used as positive controls to assess the specific immunoreactivity of
the antibodies used (Figure 2).
Analysis of the telomere length regions in the
endometria of BMT recipients
In order to search for the localization of possible niches of
endometrial SSC within the endometrium and whether XY
donor-derived cells are part of them, we examined the telomere
length in the endometrial sections from both BMT recipients and
nontransplanted patients by telomapping [43–44]. In all the
endometrial sections, hot regions associated with long telomeres
were located specifically in the stromal compartment. We did not
find differences in terms of telomere length regions with or without
BMT. In BMT recipients, most XY donor-derived cells were
randomly distributed and could not be associated with long
telomere regions (Figure 3).
Isolation of endometrial SP cells and FISH analyses of
BMT recipients
In order to investigate to what extent the donor-derived cells
from male donors participate in endometrial SP, which has been
demonstrated to constitute the SSC population [18,20,29], we first
isolated this subset of cells from the epithelial and stromal fractions
in all five BMT recipients. One interesting finding was that the
percentage of freshly epithelial SP cells was 0% in four patients,
and that 1 SP represented 0.04% of the total cell population in
only patient. In patients 1, 2 and 5, freshly stromal SP percentages
ranged from 0.01% to 0.1% (Figure 4A), and SP cells were not
isolated in patients 3 and 4 (Figure 4A). Unexpectedly, the viability
of all the analyzed samples was very low compared to
nontransplanted patients [20].
The FISH analyses of the epithelial and stromal SP from
transplanted patients revealed the absence of XY donor-derived
cells (Figure 4B). The number of cells cultured during 3 weeks in
each sample is strictly related to the initial number of SP cells
obtained from the biopsy (mean: SP 400 cells/NSP 100.000 cells).
In it context, FISH analysis was only performed in cultured cells. It
is noteworthy that one XY cell was observed in a total of 100 FISH
analyzed cells in the stroma NSP fraction of patient 4.
Discussion
We herein confirm with a pathological model of females who
received BMT from HLA-identical male donors to treat
hematologic cancers that the XY cells of a BM donor origin
migrate to the recipient’s endometrium, and transdifferentiate and
contribute to the cell composition of the stroma and the epithelial
compartment. We demonstrate that the presence of XY donor-
derived cells in the recipient’s endometrium ranges from 1.7% to
2.62%. We identify and localize 0.45% to 0.85% of the XY donor-
derived cells in the epithelial compartment displaying CD9
marker, and 1.0% to 1.83% of the XY donor-derived Vm-positive
cells in the stromal compartment. This scenario supports the
capacity of BM donor cells to give rise to endometrial tissue.
Moreover, different studies have demonstrated that multipotent
human BM donor-derived cells differentiate into cell types of the
functionally competent endometrium. For the first time, Taylor
identified in 2004 donor cells in endometrium recipients after
BMT, and confirmed their typical structural epithelial and stromal
features and their corresponding hematopoietic CD45 negative
phenotype [37]. In line with this, Ikoma [40] assessed the
unexpected plasticity of BM cells giving rise to a functional
endometrium. This they demonstrated first by the typical
expression pattern in the epithelial (Cytokeratin, Estrogen
Receptor-a) and stromal (CD10) compartments in the absence
of CD45 marker, and second by successful pregnancies in two of
the three patients analyzed. The presence of donor-derived
endothelial cells [39] in the endometrium has also been described
to contribute to the formation of new blood vessels (neovascular-
ization) in this tissue in ongoing pregnancy (one case).
Similar endometrial engraftment has been demonstrated In two
murine models, Du and Taylor demonstrated the de novo
development of the endometrium after injury due to BM stem
cells, suggesting an implication between endometriosis and
immune disorders [38]. Following BMT, Bratincsak and cols
detected donor-derived cells in the epithelial and stromal
endometria of recipient animals, where CD45 positive cells play
an important role in stromal compartment and were found to be a
putative source of cells for epithelium regeneration [46].
Furthermore, our study contributes new evidence demonstrat-
ing that XY donor-derived cells can be considered a limited
exogenous source of transdifferentiated endometrial cells rather
than a cyclic source of bone marrow-derived stem cells. First, they
were not incorporated into the endometrial SP by considering, at
least in part, the SSC population because two independent groups
have demonstrated SP ability to regenerate the human endome-
trium after cell suspension injection into the dermis [20] or the
renal capsule [18,29] of NOD-SCID mice. Nonetheless, the
possibility of BM-derived cells inducing or favoring the endome-
trial SP population in response to a physiological demand cannot
be ruled out. Secondly, XY donor-derived cells were not
associated with the SC niches assessed by telomapping as long
telomere regions [43–44]. This approach enables the analysis of
Bone Marrow Source of SC in Human Endometrium
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identify somatic stem cells in adult tissues and organs like skin [43]
and human colon [47].
Finally, engraftment percentages were very low and no
correlation was found between the time from transplant and
engraftment efficiency, suggesting random terminal differentiation,
Figure 2. Immunophenotyping of the XY donor-derived cells in the endometria of transplanted patients. (A) XY donor-derived cells
(indicated by arrows, orange and green signals) in the absence of the hematopoietic marker CD45+ (blue signal) in the recipients’ endometria. Lower
panel: spleen as a positive control for CD45 (blue). (B) Co-localization of XY donor-derived cells (indicated by arrows) with epithelial marker CD9 (blue)
in recipients’ endometria indicate the coexistence of XY+CD9+ cells in epithelial glands. Lower panel: epithelial endometrium as a positive control for
CD9 (blue). (C) Co-localization of XY donor-derived cells (indicated by arrows) with stromal marker Vm (blue) in recipients’ endometria, indicated by
the overlapping of the XY+Vm+ expression in the stromal fraction. Lower panel: stromal endometrium as a positive control for Vm (blue). All the
images were acquired using a 636/1.76oil immersion objective with a confocal microscope. Note that DAPI signals are shown in gray in all the
images.
doi:10.1371/journal.pone.0030260.g002
Figure 3. Analysis of the telomere length regions in the endometria of BMT recipients. Assessment of telomere length in the endometrial
sections from BMT recipients: note that patients 1 and 2 are represented. A color code on the left-hand side of the image symbolizes the degree of
colors corresponding to telomeric length, where long and short telomeres are represented in red and blue, respectively. Also note how the regions
associated with long telomeres are located mainly in the stromal compartment.
doi:10.1371/journal.pone.0030260.g003
Bone Marrow Source of SC in Human Endometrium
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by the absence of CD45.
In physiological terms, the transient infiltration of BM-derived
cells occurs in each menstrual cycle [11,37]. Our results indicate
that a final differentiation from the BM cell population to
endometrial tissue might occur, but that this event is not related
with endogenous endometrial stem cell capability since we have
demonstrated that no endometrial SP was of a BM origin.
Therefore, we suggest that BM cells do not contribute to the
endometrial SC pool, but might contribute to form differentiated
endometrial cells, be it to a limited extent under pathologic
conditions. Similarly, XY donor-derived cells were not detected in
the recipients’ endometrial SP fraction. We considered that in the
case of non-stem cells proliferate predominantly in vitro we must
be able to detect any XY cells as non dividing cells. Our previous
publication showed the capability of endometrial SP lines to
regenerate the whole endometrium in an animal model demon-
strating the presence and maintenance of endometrial SP cells
with stem cell features under culture conditions [29]. It seems most
unlikely that chromosome Y might be lost during engraftment, as
reported in the lung of a murine transplantation model [48],
because endometrial cells do not form the heterokaryon, and cell
fusion has been ruled out by chromosomal analyses.
Hypothetically, activation of dormant BM stem cells after stress
or injury could implicate the mobilization of these cells from BM
[49]. The questions that arise in connection with our data are
about the mechanisms controlling the differentiation of BM cells
into different endometrial cell types, and why BM contribution is
more important for the stromal than it is for the epithelial
compartment. Therefore, could BM stem cells provide factors that
favor the reactivation of the damaged endometrial niche?
It is surprising that in our study we discovered that SP reduced if
compared to nontransplanted patients because of chemothera-
peutic agents. Nevertheless, the largest retrospective study, which
consists in 229 centers of the European Group for Blood and
Marrow Transplantation (EBMT) and includes patients who
conceived naturally or by assisted reproductive techniques (ART)
after BMT, demonstrates that the recipients’ endometria were
functional and concludes that the outcome of a pregnancy after
BMT is likely to be successful [50].
The latest publication about this topic assessed endometrial
renewal in an Asherman’s syndrome patient throughout the
intrauterine administration of BM stem cells. The clinical evidence
deriving from this study confirms the feasible stimulation of
dormant endometrial stem cells to a cell proliferation status to help
regenerate the damaged endometrium [51].
Figure 4. Isolation of endometrial SP cells and FISH analyses from BMT recipients. (A) Table indicating the percentages of freshly
endometrial SP cells obtained in all 5 patients by a cell sorter analysis. Percentages are provided for both the epithelial and stromal fractions. (B)
Diagram showing a typical SP graph and the results of the FISH analyses of epithelial and stromal SP cells, revealing the absence of XY donor-derived
cells.
doi:10.1371/journal.pone.0030260.g004
Bone Marrow Source of SC in Human Endometrium
PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e30260In short, we confirm the presence of XY donor-derived cells of a
BM origin in the endometria of transplanted recipients, which
suggests a high plasticity process to renew endometrial tissue.
Furthermore, we demonstrate that XY donor-derived cells from
BM can be considered an exogenous source of transdifferentiated
endometrial cells, be it to a limited extent, rather than a cyclic
source of BM-derived stem cells.
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